Modeling the drug transport in the anterior segment of the eye

被引:23
作者
Avtar, Ram [1 ]
Tandon, Deepti [1 ]
机构
[1] Harcourt Butler Technol Inst, Dept Math, Kanpur 2008002, Uttar Pradesh, India
关键词
metabolism; anterior chamber; pharmacokinetic; topical;
D O I
10.1016/j.ejps.2008.06.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: The aim of the present work is the development of a simple mathematical model for the time course concentration profile of topically administered drugs in the anterior chamber aqueous humor and investigation of the effects of various model parameters on the aqueous humor concentration of lipophilic and hydrophilic drugs. Method: A simple pharmacokinetic model for the transient drug transport in the anterior segment has been developed by using the conservation of mass in the precorneal tear film, Fick's law of diffusion and Michaelis-Menten kinetics of drug metabolism in cornea, and the conservation of mass in the anterior chamber. An analytical solution describing the drug concentration in the anterior chamber has been obtained. Result: The model predicts that an increase in the drug metabolic (consumption) rate in the corneal epithelium reduces the drug concentration in the anterior chamber for both lipophilic and hydrophilic molecules. A decrease in the clearance rate and distribution volume of the drug in the anterior chamber raises the aqueous humor concentration significantly. It is also observed that decay rate of drug concentration in the anterior chamber is higher for lipophilic molecules than that for hydrophilic molecules. Conclusion: The bioavailability of drugs applied topically to the eye may be improved by a rise in the precorneal tear volume, diffusion coefficient in corneal epithelium and distribution coefficient across the endothelium anterior chamber interface, and by reducing the drug metabolism, drug clearance rate and distribution volume in anterior chamber. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 12 条
[1]   Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems [J].
Bodor, N ;
Buchwald, P .
AAPS JOURNAL, 2005, 7 (04) :E820-E833
[2]   Biopharmaceutical considerations in topical ocular drug delivery [J].
Davies, NM .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (07) :558-562
[3]   PRELIMINARY PHARMACOKINETIC MODEL OF PILOCARPINE UPTAKE AND DISTRIBUTION IN EYE [J].
HIMMELSTEIN, KJ ;
GUVENIR, I ;
PATTON, TF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (05) :603-606
[4]   Drug delivery to the eye with a transdermal therapeutic system [J].
Isowaki, A ;
Ohtori, A ;
Matsuo, Y ;
Tojo, K .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (01) :69-72
[5]  
KAKUJI TO, 1988, MATH BIOSCI, V89, P53
[6]  
Lee V H, 1986, J Ocul Pharmacol, V2, P67, DOI 10.1089/jop.1986.2.67
[7]   A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR THE INTRAOCULAR DISTRIBUTION OF PILOCARPINE IN RABBITS [J].
MILLER, SC ;
HIMMELSTEIN, KJ ;
PATTON, TF .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (06) :653-677
[8]   MECHANISM OF TRANSCORNEAL PERMEATION OF PILOCARPINE [J].
MITRA, AK ;
MIKKELSON, TJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (09) :771-775
[9]  
PATTON F, 1985, INVEST OPHTH VIS SCI, V26, P584
[10]   Penetration into the anterior chamber via the conjunctival/scleral pathway [J].
Schoenwald, RD ;
Deshpande, GS ;
Rethwisch, DG ;
Barfknecht, CF .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1997, 13 (01) :41-59